Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 2;3(10):102286.
doi: 10.1016/j.jscai.2024.102286. eCollection 2024 Oct.

Addressing Knowledge Gaps in Patients With High-Risk Peripheral Artery Disease

Affiliations
Editorial

Addressing Knowledge Gaps in Patients With High-Risk Peripheral Artery Disease

R Kevin Rogers et al. J Soc Cardiovasc Angiogr Interv. .
No abstract available

Keywords: lower extremity revascularization; peripheral artery disease; risk stratification; superficial femoral artery disease.

PubMed Disclaimer

Comment on

  • doi: 10.1016/j.jscai.2024.102241

References

    1. Fowkes F.G.R., Aboyans V., Fowkes F.J.I., McDermott M.M., Sampson U.K.A., Criqui M.H. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol. 2017;14(3):156–170. doi: 10.1038/nrcardio.2016.179. - DOI - PubMed
    1. Bradbury A.W., Moakes C.A., Popplewell M., et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401(10390):1798–1809. doi: 10.1016/S0140-6736(23)00462-2. - DOI - PubMed
    1. Farber A., Menard M.T., Conte M.S., et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387(25):2305–2316. doi: 10.1056/NEJMoa2207899. - DOI - PubMed
    1. Bonaca M.P., Creager M.A. Antithrombotic therapy and major adverse limb events in peripheral artery disease: a step forward. J Am Coll Cardiol. 2018;71(20):2316–2318. doi: 10.1016/j.jacc.2018.04.001. - DOI - PubMed
    1. Murphy T.P., Cutlip D.E., Regensteiner J.G., et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65(10):999–1009. doi: 10.1016/j.jacc.2014.12.043. - DOI - PMC - PubMed

Publication types

LinkOut - more resources